New high intensity fibreoptic phototherapy devices in healthy newborns: a single pad wrapped around the neonate body in comparison with a double pad device

R Luciano, G Mancini, F Cota, A Romano, V Purcaro, F Lerro, M Corsello, G Vento, R Luciano, G Mancini, F Cota, A Romano, V Purcaro, F Lerro, M Corsello, G Vento

Abstract

Background: Fibreoptic Phototherapy (FPT) allows to lower total serum bilirubin (TSB) levels in healthy neonates maintained in rooming-in with their mothers. The 2004 Cochrane review showed that, differently from preterm neonates, FPT was not as effective as traditional phototherapy in term neonates (TN), unless the simultaneous utilization of two FPT devices. Aim of this study was to compare the efficacy of two FPT devices, both equipped with a single light-emitting diode (LED): the first one has a single large pad wrapped around the infant body (Bilisoft, GE Health Care) (device A), the second one is a double-pad phototherapy device (BiliCocoon, CremascolieIris) (device B).

Methods: We studied 172 healthy neonates with non-hemolytic hyperbilirubinaemia: 57 TN and 57 late preterm neonates (LPN) treated with device A (Group 1); 47 TN and 11 LPN treated with device B (Group 2). We evaluated the differences between groups by the Student's t-test for continuous variables and by chi square test for categorical data. A two tailed p < 0.05 was considered significant.

Results: There were no differences in term of duration of FPT, TSB hourly reduction, percentage of TSB reduction after FPT, TSB maximum rebound, percentage of TSB increase after FPT discontinuation and number of after-discharge checks. Two neonates treated with device B showed no decrease in TSB values during FPT. Seven infants treated with device B experienced hyperpyrexia.

Conclusions: The two LED FPT devices were both effective in lowering TSB either in TN or LPN. Device A was effective in all treated neonates without negative side effects during treatment; device B was effective in all but 2 infants and 12% of the neonates in the same group experienced hyperpyrexia. According to our results, the single big pad wrapped around the infant body has the same efficacy as a double FPT device in TN and LPN.

Keywords: Hyperbilirubinaemia; Jaundice; Newborn; Phototherapy.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
    1. Bhutani VK. Committee on the fetus and newborn, American Academy of Pediatrics. Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2011;128:1046–1052. doi: 10.1159/000113463.
    1. Tan KL. Comparison of the efficacy of fiberoptic and conventional phototherapy for neonatal hyperbilirubinemia. J Pediatr. 1994;125(4):607–612. doi: 10.1016/S0022-3476(94)70019-2.
    1. Sarici SU, Alpay F, Unay B, Ozcan O, Gökçay E. Comparison of the efficacy of conventional special blue light phototherapy and fiberoptic phototherapy in the management of neonatal hyperbilirubinaemia. Acta Paediatr. 1999;88(11):1249–1253. doi: 10.1111/j.1651-2227.1999.tb01026.x.
    1. Mills JF, Tudehope D. Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev. 2001. 10.1002/14651858.
    1. Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates (review). Cochrane Libr. 2011:12. 10.1002/14651858.
    1. Luciano R, Rubortone SA, Cota F, Mancini G, Proli F, Romagnoli C. Fiberoptic phototherapy in the rooming-in unit: a comparison between term and late preterm infants. Journal of Pediatric and Neonatal Individualized Medicine. 2016;5(2):e050248. doi: 10.7363/050248.
    1. Romagnoli C, Romagnoli C, Dani C, Pratesi S, Raimondi F, Capasso L, Zecca E. Task force per l’iperbilirubinemia neonatale della Società Italiana di Neonatologia Raccomandazioni per il trattamento dell’iperbilirubinemia neonatale Ed Biomedia. 2013.
    1. Seidman DS, Moise J, Ergaz Z, Laor A, Vreman HJ, Stevenson DK, et al. A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol. 2003;23:123–127. doi: 10.1038/sj.jp.7210862.
    1. Maisels MJ, Kring EA, DeRidder J. Randomized controlled trial of light-emitting diode phototherapy. J Perinatol. 2007;27:565–567. doi: 10.1038/sj.jp.7211789.
    1. Sherbiny et al. High-intensity light-emitting diode vs fluorescent tubes for intensive phototherapy in neonates. Paediatr Int Child Health. 2016;36(2):127–133. doi: 10.1179/2046905515Y.0000000006.
    1. Woodall D, Karas JG. A new light on jaundice. Clin Pediatr. 1992;31:353–356. doi: 10.1177/000992289203100607.
    1. Donzelli GP, Moroni M, Rapisardi G, Agati G, Fusi F. Fibreoptic phototherapy in the management of jaundice in low birthweight infants. Acta Paediatr. 1996;85:366–370. doi: 10.1111/j.1651-2227.1996.tb14034.x.
    1. van Kaam AHLC, van Beek RHT, Vergunst-van Keulen JG, van der Heijden J, Lutz-Dettinger N, Hop W, Sauer PJJ. Fibre optic versus conventional phototherapy for hyperbilirubinaemia in preterm infants. Eur J Pediatr. 1998;157:132–137. doi: 10.1007/s004310050785.
    1. Kumar P, Murki S, Malik GK, Chawla D, Deorari AK, Karthi N, et al. Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial. Indian Pediatr. 2010;47(2):131–137. doi: 10.1007/s13312-010-0020-7.
    1. Morris B H, Tyson J E, Stevenson D K, Oh W, Phelps D L, O'Shea T M, McDavid G E, Van Meurs K P, Vohr B R, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins R D. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. Journal of Perinatology. 2012;33(2):126–133. doi: 10.1038/jp.2012.39.
    1. George P, Lynch M. Ohmeda Bililanket vs wallaby phototherapy system for the reduction of bilirubin levels in the home-care setting. Clin Pediatr. 1994;33:178–180. doi: 10.1177/000992289403300313.
    1. Romagnoli et al. Which phototherapy system is Most effective in lowering serum bilirubin in very preterm infants? Fetal Diagn Ther. 2006;21:204–209. doi: 10.1159/000089304.
    1. Ng/Carlisle/Ly/Morris Heating of newborn infants due to blue light-emitting diode Fibreoptic phototherapy pads. Neonatology. 2017;112:103–109. doi: 10.1159/000464318.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj